As of 2026-09-29, the Relative Valuation of ALX Oncology Holdings Inc (ALXO) is (17.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.39 USD, the upside of ALX Oncology Holdings Inc based on Relative Valuation is -1323.9%.
The range of the Relative Valuation is (15.57) - (18.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.8x - 30.4x | 28.1x |
| Forward P/E multiples | 25.9x - 31.1x | 28.5x |
| Fair Price | (15.57) - (18.27) | (17.01) |
| Upside | -1220.1% - -1414.7% | -1323.9% |
| Date | P/E |
| 2026-09-28 | -2.31 |
| 2026-09-25 | -2.18 |
| 2026-09-24 | -2.25 |
| 2026-09-23 | -2.45 |
| 2026-09-22 | -2.66 |
| 2026-09-21 | -2.76 |
| 2026-09-18 | -2.83 |
| 2026-09-17 | -2.89 |
| 2026-09-16 | -2.93 |
| 2026-09-15 | -3.14 |
| 2026-09-14 | -3.20 |
| 2026-09-11 | -3.23 |
| 2026-09-10 | -3.16 |
| 2026-09-09 | -3.06 |
| 2026-09-08 | -3.33 |
| 2026-09-04 | -3.34 |
| 2026-09-03 | -3.38 |
| 2026-09-02 | -3.46 |
| 2026-09-01 | -3.29 |
| 2026-08-31 | -3.21 |
| 2026-08-28 | -3.33 |
| 2026-08-27 | -3.41 |
| 2026-08-26 | -3.29 |
| 2026-08-25 | -3.33 |
| 2026-08-24 | -3.31 |
| 2026-08-21 | -3.39 |
| 2026-08-20 | -3.31 |
| 2026-08-19 | -3.43 |
| 2026-08-18 | -3.46 |
| 2026-08-17 | -3.28 |
| 2026-08-14 | -3.26 |
| 2026-08-13 | -3.23 |
| 2026-08-12 | -3.34 |
| 2026-08-11 | -3.21 |
| 2026-08-10 | -3.43 |
| 2026-08-07 | -3.49 |
| 2026-08-06 | -3.51 |
| 2026-08-05 | -3.19 |
| 2026-08-04 | -3.28 |
| 2026-08-03 | -3.21 |
| 2026-07-31 | -3.23 |
| 2026-07-30 | -3.24 |
| 2026-07-29 | -3.24 |
| 2026-07-28 | -3.31 |
| 2026-07-27 | -3.36 |
| 2026-07-24 | -3.38 |
| 2026-07-23 | -3.36 |
| 2026-07-22 | -3.36 |
| 2026-07-21 | -3.41 |
| 2026-07-20 | -3.19 |